Makers Laboratories Ltd.

MAKERSL

₹154.0

-0.03% (-0.05)

Market Cap

₹91 Cr.

P/E

12.13

About

Makers Laboratories Ltd is engaged in manufacturing pharmaceutical formulations and drug intermediaries.The product portfolio of the company includes Tablets & Capsules,Liquids (Oral),Injectables,Dru… Read more

Makers Laboratories Ltd is engaged in manufacturing pharmaceutical formulations and drug inte… Read more

Low

122

52W Range

High

230

Timeline

Key company specific updates

Company Timeline

Custom financial statementNew

Edit rows

In Rs. Cr.	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025

In Rs. Cr.	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Balance sheet
Net Block	—	—	—	—	—	71.39	68.30	84.52	86.57	72.50
Shareholders Funds	—	—	—	—	—	54.13	59.58	69.20	63.05	70.51
Profit & Loss
Operating Profit	—	—	—	—	—	8.12	18.84	3.32	1.12	8.39
Net Sales	—	—	—	—	—	68.64	127	101	104	121
Cash flow
Cash from Operating Activity	—	—	—	—	—	—	18.50	-8.62	0.84	-4.08
Net Capex (est)	—	—	—	—	—	—	9.28	12.50	6.46	-14.88
Ratios
ROCE (%)	—	—	—	—	—	4.33	15.65	1.09	-1.53	—
ROE (%)	—	—	—	—	—	-0.61	8.36	-6.87	-9.94	—

Forensics

8 Yes

Positive for this company

1 Neutral

Neutral for this company

8 No

Negative for this company

0 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Pledge

Promoters have not pledged a significant portion of their holding
Retail Holding

Retail has been selling the stock which is usually a good time to buy
Revenue Recognition

Company is converting accounting profit to cash
Promoter Holding

Promoter has not sold any shares in the last 90 days
Depreciation Effect

Company is depreciating a lower percentage of assets. this is contributing to an increase in net profit
Other Income

Other income component is making ratios of the company look optically better

Price & Performance

ROE

Asset turnover is responsible for roe increase over last 10 years
Share price

Share price has increased over last 10 years due to earnings
Current vs Historic Valuation

Company is trading at a discount to 3yr historic valuations
Sales Growth

Sales of the company has grown at a good pace
Capex vs ROCE

Roce of the company has decreased even without significant capex
Debt

Company might have issues servicing its debt
Working Capital

Company has significant working capital which is dragging its roce and roe
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong
Balance Sheet Strength

Balance sheet is weak and might have solvency issues

Revenue mix

Product Wise Break-Up

Segment Break-Up

Location Wise Break-Up

Operating Profit Break-Up

Asset Break-Up

Peer Comparison

Peer Name	Latest Price	PE	Market cap(Cr)	Prom Holding(%)	YoY Qtly Sales(%)	ROCE (%)	ROE (%)
Makers Laboratories	155.75	12.13	91	61.27	21.91	-1.53	-9.94
Ind-Swift	16.92	1.48	95	55.58	17.13	23.76	-2.06
Achyut Healthcare	3.6	149.59	82	46.11	—	2.42	1.86
Biofil Chem & Pharma	50.61	145.32	81	46.82	-45.07	4.89	3.9
Bharat Immunological	24.69	0.00	109	59.25	-100	-22.38	-18.86
Dipna Pharma.	21.6	48.83	53	9.98	—	6.97	2.89
JFL Life Sciences	16.05	12.14	50	67.47	-45.94	12.66	9.3
Deccan Health Care	21.05	41.03	48	19.46	29.93	2.29	1.54

Corporate Actions

Consolidated DividendRights

DATE

DETAILS

2022, Mar 30

Rights 1 rights eligible for every 5 shares held.

2019, Aug 01

Dividend Dividend of Rs.1 per share

2018, Jul 26

Dividend Dividend of Rs.1 per share

2017, Jul 20

Dividend Dividend of Rs.1 per share

2016, Aug 02

Dividend Dividend of Rs.1 per share

FAQs on Makers Laboratories Ltd. Business

What does Makers Laboratories do?

Makers Laboratories Ltd specializes in manufacturing pharmaceutical formulations and drug intermediaries, offering a wide range of products including tablets, capsules, liquids, injectables, drugs intermediates, creams, and ointments.

Who are the competitors of Makers Laboratories?

Makers Laboratories major competitors are Ind-Swift, Achyut Healthcare, Biofil Chem & Pharma, Bharat Immunological, Dipna Pharma., JFL Life Sciences, Deccan Health Care.
Market Cap of Makers Laboratories is ₹91 Crs.
While the median market cap of its peers are ₹81 Crs.

Is Makers Laboratories financially stable compared to its competitors?

Makers Laboratories seems to be less financially stable compared to its competitors.
Altman Z score of Makers Laboratories is 1.84 and is ranked 6 out of its 8 competitors.

View FAQ's On Shareprice

Global Leaders

Companies with a dominant global position in a product. Might be a sign of very strong moat.

Run Query

Reasonably Valued Domestic Healthcare Companies

Healthcare companies trading at a decent valuation

Run Query

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Makers Laboratories Ltd.

Makers Laboratories Ltd.

About

Timeline

Company Timeline

8 Yes

1 Neutral

8 No

0 No Data

Accounting & Shareholding

Contingent Liabilities

Pledge

Retail Holding

Revenue Recognition

Promoter Holding

Depreciation Effect

Other Income

Price & Performance

ROE

Share price

Current vs Historic Valuation

Sales Growth

Capex vs ROCE

Debt

Working Capital

Margin Stability

ROCE Strength

Balance Sheet Strength

Product Wise Break-Up

UNLOCK PREMIUM

Segment Break-Up

UNLOCK PREMIUM

Location Wise Break-Up

UNLOCK PREMIUM

Operating Profit Break-Up

UNLOCK PREMIUM

Asset Break-Up

UNLOCK PREMIUM

What does Makers Laboratories do?

Who are the competitors of Makers Laboratories?

Is Makers Laboratories financially stable compared to its competitors?

SIGN UP FOR FREE